138 related articles for article (PubMed ID: 16314444)
1. 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.
Khadzkou K; Buchwald P; Westin G; Dralle H; Akerström G; Hellman P
J Histochem Cytochem; 2006 Mar; 54(3):355-61. PubMed ID: 16314444
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma.
Izkhakov E; Somjen D; Sharon O; Knoll E; Aizic A; Fliss DM; Limor R; Stern N
J Steroid Biochem Mol Biol; 2016 May; 159():26-30. PubMed ID: 26907966
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
6. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
[TBL] [Abstract][Full Text] [Related]
8. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
9. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.
Lo CY; Lam KY; Leung PP; Luk JM
Eur J Endocrinol; 2005 Apr; 152(4):545-50. PubMed ID: 15817909
[TBL] [Abstract][Full Text] [Related]
11. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.
Cerutti JM; Oler G; Michaluart P; Delcelo R; Beaty RM; Shoemaker J; Riggins GJ
Cancer Res; 2007 Aug; 67(16):7885-92. PubMed ID: 17699795
[TBL] [Abstract][Full Text] [Related]
13. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
[TBL] [Abstract][Full Text] [Related]
14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.
Somjen D; Grafi-Cohen M; Posner GH; Sharon O; Kraiem Z; Stern N
J Steroid Biochem Mol Biol; 2013 Jul; 136():80-2. PubMed ID: 23059472
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
Segersten U; Björklund P; Hellman P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.
de Araujo-Filho VJ; Alves VA; de Castro IV; Lourenço SV; Cernea CR; Brandão LG; Ferraz AR
Thyroid; 2009 Nov; 19(11):1233-7. PubMed ID: 19888861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]